Does increased production of soluble CTLA-4 in patients with spondylarthropathies correlate with disease activity?
SpA patients exhibit high levels of circulating sCTLA-4 that may result from an alternative splicing of CTLA-4 transcripts. This may influence immune activation and regulation in SpA.
Routine specialist visits for women initially at low risk of pregnancy complications offer little or no clinical or consumer benefit.